{"transactions":[{"id":788586,"issuer":{"id":3469,"kind":"organization","name":"BrightSpring Health Services, Inc.","symbol":"BTSG"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-07T22:31:03.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":4983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 5, 2026, the Reporting Person was granted restricted stock units (\"RSUs\") which fully vest on May 5, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement."}],"balance_after":23106,"source":{"system":"sec-edgar","filing":"0000908834-26-000217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865782/000090883426000217/form4.xml","form_type":"4"}},{"id":1005883,"issuer":{"id":3469,"kind":"organization","name":"BrightSpring Health Services, Inc.","symbol":"BTSG"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-06T21:06:24.000Z","date":"2025-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":4497,"price":32.68,"value":146961.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock withheld by the Issuer to satisfy withholding taxes due in connection with the vesting of 10,708 restricted stock units at a net settlement price equal to the closing stock price on November 5, 2025."}],"balance_after":18123,"source":{"system":"sec-edgar","filing":"0000908834-25-000319","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865782/000090883425000319/form4.xml","form_type":"4"}},{"id":1156276,"issuer":{"id":3469,"kind":"organization","name":"BrightSpring Health Services, Inc.","symbol":"BTSG"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-07T20:09:34.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":11912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 5, 2025, the Reporting Person was granted restricted stock units (\"RSUs\") which fully vest on May 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,708 shares of the Issuer's common stock underlying RSUs which fully vest on November 5, 2025 and 11,912 shares of the Issuer's common stock underlying RSUs which fully vest on May 5, 2026."}],"balance_after":22620,"source":{"system":"sec-edgar","filing":"0000908834-25-000144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865782/000090883425000144/form4.xml","form_type":"4"}},{"id":1371570,"issuer":{"id":3469,"kind":"organization","name":"BrightSpring Health Services, Inc.","symbol":"BTSG"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-08T23:18:16.000Z","date":"2024-11-05","kind":"grant","planned":false,"acquired":true,"shares":10708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 5, 2024, the Reporting Person was granted restricted stock units (\"RSUs\") which fully vest on November 5, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,708 shares of the Issuer's common stock underlying RSUs, as described in footnote 1 herein."}],"balance_after":10708,"source":{"system":"sec-edgar","filing":"0000908834-24-000302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865782/000090883424000302/form4.xml","form_type":"4"}},{"id":2820736,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:56.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":1715,"price":210.31,"value":360681.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":28439,"source":{"system":"sec-edgar","filing":"0001225208-21-004366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004366/doc4.xml","form_type":"4"}},{"id":2820735,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:56.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":840,"price":209.9,"value":176316.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units."}],"balance_after":30154,"source":{"system":"sec-edgar","filing":"0001225208-21-004366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004366/doc4.xml","form_type":"4"}},{"id":2820734,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:56.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":383,"price":210.31,"value":80548.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":30994,"source":{"system":"sec-edgar","filing":"0001225208-21-004366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004366/doc4.xml","form_type":"4"}},{"id":2820733,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:56.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":3831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":31377,"source":{"system":"sec-edgar","filing":"0001225208-21-004366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004366/doc4.xml","form_type":"4"}},{"id":2829906,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-27T01:22:38.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":6134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning March 1, 2022."}],"balance_after":6134,"derivative":{"exercise_price":213.8,"exercise_date":"2022-03-01","expiration_date":"2031-02-24","underlying":"Common Stock, $.01 Par Value","underlying_shares":6134},"source":{"system":"sec-edgar","filing":"0001225208-21-003975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821003975/doc4.xml","form_type":"4"}},{"id":2829905,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-02-27T01:22:38.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":1287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning March 1, 2022."}],"balance_after":27546,"source":{"system":"sec-edgar","filing":"0001225208-21-003975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821003975/doc4.xml","form_type":"4"}},{"id":2874618,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-02-08T23:23:51.000Z","date":"2021-02-04","kind":"tax_withholding","acquired":false,"shares":622,"price":210.53,"value":130949.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":26259,"source":{"system":"sec-edgar","filing":"0001225208-21-001888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821001888/doc4.xml","form_type":"4"}},{"id":2912356,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-08T22:31:51.000Z","date":"2021-01-07","kind":"exercise","acquired":false,"shares":777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 5, 2014. The option vested in three equal annual installments on February 28, 2015, February 28, 2016, and February 28, 2017."}],"balance_after":0,"derivative":{"exercise_price":160.6623,"expiration_date":"2021-03-05","underlying":"Common Stock, $.01 Par Value","underlying_shares":777},"source":{"system":"sec-edgar","filing":"0001225208-21-000701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821000701/doc4.xml","form_type":"4"}},{"id":2912355,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-08T22:31:51.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":8972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 5, 2014. The option vested in three equal annual installments on February 28, 2015, February 28, 2016, and February 28, 2017."}],"balance_after":777,"derivative":{"exercise_price":160.6623,"expiration_date":"2021-03-05","underlying":"Common Stock, $.01 Par Value","underlying_shares":8972},"source":{"system":"sec-edgar","filing":"0001225208-21-000701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821000701/doc4.xml","form_type":"4"}},{"id":2912354,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-01-08T22:31:51.000Z","date":"2021-01-07","kind":"exercise","acquired":true,"shares":777,"price":160.6623,"value":124834.6071,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":26881,"source":{"system":"sec-edgar","filing":"0001225208-21-000701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821000701/doc4.xml","form_type":"4"}},{"id":2912353,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-01-08T22:31:51.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":8972,"price":210,"value":1884120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":26104,"source":{"system":"sec-edgar","filing":"0001225208-21-000701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821000701/doc4.xml","form_type":"4"}},{"id":2912352,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-01-08T22:31:51.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":8972,"price":160.6623,"value":1441462.1556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020."}],"balance_after":35076,"source":{"system":"sec-edgar","filing":"0001225208-21-000701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821000701/doc4.xml","form_type":"4"}},{"id":3238535,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:19.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":1426,"price":182.94,"value":260872.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units."}],"balance_after":26104,"source":{"system":"sec-edgar","filing":"0001225208-20-003962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003962/doc4.xml","form_type":"4"}},{"id":3238534,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:19.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":858,"price":179.41,"value":153933.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":27530,"source":{"system":"sec-edgar","filing":"0001225208-20-003962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003962/doc4.xml","form_type":"4"}},{"id":3238533,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:19.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":28388,"source":{"system":"sec-edgar","filing":"0001225208-20-003962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003962/doc4.xml","form_type":"4"}},{"id":3238532,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:47:19.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":149,"price":185.76,"value":27678.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":26210,"source":{"system":"sec-edgar","filing":"0001225208-20-003962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003962/doc4.xml","form_type":"4"}},{"id":3241408,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-29T02:27:15.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":5243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning February 26, 2021."}],"balance_after":5243,"derivative":{"exercise_price":192.02,"exercise_date":"2021-02-26","expiration_date":"2030-02-26","underlying":"Common Stock, $.01 Par Value","underlying_shares":5243},"source":{"system":"sec-edgar","filing":"0001225208-20-003811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003811/doc4.xml","form_type":"4"}},{"id":3241407,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-02-29T02:27:15.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":1433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vests in three equal annual installments beginning February 26, 2021."}],"balance_after":26359,"source":{"system":"sec-edgar","filing":"0001225208-20-003811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003811/doc4.xml","form_type":"4"}},{"id":3274384,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-13T23:07:15.000Z","date":"2020-02-11","kind":"exercise","acquired":false,"shares":8406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 6, 2013.  The option vested in three equal annual installments on February 28, 2014, February 28, 2015 and February 28, 2016."}],"balance_after":0,"derivative":{"exercise_price":121.1371,"expiration_date":"2020-03-06","underlying":"Common Stock, $.01 Par Value","underlying_shares":8406},"source":{"system":"sec-edgar","filing":"0001225208-20-002233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820002233/doc4.xml","form_type":"4"}},{"id":3274383,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-02-13T23:07:15.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":7145,"price":212.1538,"value":1515838.901,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $211.546 to $212.46 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":24926,"source":{"system":"sec-edgar","filing":"0001225208-20-002233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820002233/doc4.xml","form_type":"4"}},{"id":3274382,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-02-13T23:07:15.000Z","date":"2020-02-11","kind":"exercise","acquired":true,"shares":8406,"price":121.1371,"value":1018278.4626,"ownership":{"direct":true},"balance_after":32071,"source":{"system":"sec-edgar","filing":"0001225208-20-002233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820002233/doc4.xml","form_type":"4"}},{"id":3619504,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-04T23:39:20.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":1881,"price":174.44,"value":328121.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units."}],"balance_after":23665,"source":{"system":"sec-edgar","filing":"0001225208-19-004413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004413/doc4.xml","form_type":"4"}},{"id":3623409,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"exercise","acquired":false,"shares":1116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents options that were automatically exercised immediately prior to their expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Stock option previously awarded pursuant to Express Scripts, Inc. 2011 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":110.4749,"exercise_date":"2014-02-28","expiration_date":"2019-02-27","underlying":"Common Stock, $.01 Par Value","underlying_shares":1116},"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623408,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":5179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests in three equal annual installments beginning February 27, 2020."}],"balance_after":5179,"derivative":{"exercise_price":183.4405,"exercise_date":"2020-02-27","expiration_date":"2029-02-27","underlying":"Common Stock, $.01 Par Value","underlying_shares":5179},"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623407,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"exercise","acquired":false,"shares":12566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents options that were automatically exercised immediately prior to their expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock option previously awarded pursuant to Express Scripts, Inc. 2011 Long-Term Incentive Plan.  Options vested in three equal annual installments on February 28, 2013, February 28, 2014, and February 28, 2015."}],"balance_after":0,"derivative":{"exercise_price":110.4749,"expiration_date":"2019-02-27","underlying":"Common Stock, $.01 Par Value","underlying_shares":12566},"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623406,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"tax_withholding","acquired":false,"shares":9135,"price":180.72,"value":1650877.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares tendered to Company to cover payment of exercise price and tax liability due upon exercise of stock option."}],"balance_after":25546,"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623405,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"tax_withholding","acquired":false,"shares":812,"price":180.72,"value":146744.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares tendered to Company to cover payment of exercise price and tax liability due upon exercise of stock option."}],"balance_after":34681,"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623404,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"exercise","acquired":true,"shares":1116,"price":110.4749,"value":123289.9884,"ownership":{"direct":true},"balance_after":35493,"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623403,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning February 27, 2020."}],"balance_after":34377,"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3623402,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:24:49.000Z","date":"2019-02-27","kind":"exercise","acquired":true,"shares":12566,"price":110.4749,"value":1388227.5934,"ownership":{"direct":true},"balance_after":32877,"source":{"system":"sec-edgar","filing":"0001225208-19-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004249/doc4.xml","form_type":"4"}},{"id":3674586,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Phantom Stock Units","published_at":"2019-02-06T00:05:58.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":154.6726,"price":194.06,"value":30015.764756,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Phantom Stock Units credited under Express Scripts Executive Deferred Compensation Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon distribution, each Phantom Stock Unit converts to one share of Cigna Corporation Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Basic Company Credit by Cigna Corporation to Participant's account in the Express Scripts Executive Deferred Compensation Plan; the Basic Company Credit is fully vested once credited to the Participant's account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Basic Company Credit by Cigna Corporation to Participant's account in the Express Scripts Executive Deferred Compensation Plan; the Basic Company Credit is fully vested once credited to the Participant's account."}],"balance_after":1118.6726,"derivative":{"exercise_price":0,"underlying":"Common Stock, $.01 Par Value","underlying_shares":154.6726},"source":{"system":"sec-edgar","filing":"0001225208-19-001829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819001829/doc4.xml","form_type":"4"}},{"id":3674585,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"officer":true,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-02-06T00:05:58.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":4179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Total holdings were increased by one share of common stock due to a rounding error on the Form 4 report that was filed on December 26, 2018."}],"balance_after":20311,"source":{"system":"sec-edgar","filing":"0001225208-19-001829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819001829/doc4.xml","form_type":"4"}},{"id":3719243,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Phantom Stock Units","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":964,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"In accordance with the terms of the Merger Agreement, each phantom stock unit outstanding immediately prior to the Effective Time was automatically converted into a phantom stock unit, with the same terms and conditions, relating to the number of shares of New Cigna Common Stock determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"In accordance with the terms of the Merger Agreement, each phantom stock unit outstanding immediately prior to the Effective Time was automatically converted into a phantom stock unit, with the same terms and conditions, relating to the number of shares of New Cigna Common Stock determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"In accordance with the terms of the Merger Agreement, each phantom stock unit outstanding immediately prior to the Effective Time was automatically converted into a phantom stock unit, with the same terms and conditions, relating to the number of shares of New Cigna Common Stock determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"In accordance with the terms of the Merger Agreement, each phantom stock unit outstanding immediately prior to the Effective Time was automatically converted into a phantom stock unit, with the same terms and conditions, relating to the number of shares of New Cigna Common Stock determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"In accordance with the terms of the Merger Agreement, each phantom stock unit outstanding immediately prior to the Effective Time was automatically converted into a phantom stock unit, with the same terms and conditions, relating to the number of shares of New Cigna Common Stock determined in accordance with the terms of the Merger Agreement."}],"balance_after":964,"derivative":{"underlying":"Common Stock, $0.01 Par Value","underlying_shares":964},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719242,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":19854,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase shares of New Cigna Common Stock, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020."}],"balance_after":19854,"derivative":{"exercise_price":140.8164,"expiration_date":"2027-03-08","underlying":"Common Stock, $0.01 Par Value","underlying_shares":19854},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719241,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":17551,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase shares of New Cigna Common Stock, with the remaining one-third of the option vesting on February 28, 2019."}],"balance_after":17551,"derivative":{"exercise_price":144.8772,"expiration_date":"2026-03-09","underlying":"Common Stock, $0.01 Par Value","underlying_shares":17551},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719240,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":2793,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":2793,"derivative":{"exercise_price":180.7997,"expiration_date":"2025-12-01","underlying":"Common Stock, $0.01 Par Value","underlying_shares":2793},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719239,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":10646,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":10646,"derivative":{"exercise_price":176.6556,"expiration_date":"2025-03-04","underlying":"Common Stock, $0.01 Par Value","underlying_shares":10646},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719238,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":9749,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":9749,"derivative":{"exercise_price":160.6623,"expiration_date":"2021-03-05","underlying":"Common Stock, $0.01 Par Value","underlying_shares":9749},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719237,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":8406,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":8406,"derivative":{"exercise_price":121.1371,"expiration_date":"2020-03-06","underlying":"Common Stock, $0.01 Par Value","underlying_shares":8406},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719236,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":12566,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":12566,"derivative":{"exercise_price":110.4749,"expiration_date":"2019-02-27","underlying":"Common Stock, $0.01 Par Value","underlying_shares":12566},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719235,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":1116,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":1116,"derivative":{"exercise_price":110.4749,"expiration_date":"2019-02-27","underlying":"Common Stock, $0.01 Par Value","underlying_shares":1116},"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719234,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"tax_withholding","acquired":true,"shares":14253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares withheld to satisfy tax obligations upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":16131,"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719233,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":14864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of New Cigna Common Stock received in exchange for Express Scripts performance share units.  In accordance with the terms of the Merger Agreement, each performance share unit of Express Scripts outstanding was cancelled at the Effective Time in exchange for (1) 0.2434 of a share of New Cigna Common Stock and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":30384,"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719232,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":9854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents New Cigna restricted stock units received in exchange for Express Scripts restricted stock units.  In accordance with the terms of the Merger Agreement, each restricted stock unit of Express Scripts outstanding immediately prior to the Effective Time was automatically converted into a restricted stock unit of New Cigna with the same terms and conditions and relating to the number of shares of New Cigna Common Stock determined in accordance with the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":15520,"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3719231,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Clinical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:18:52.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":5666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":5666,"source":{"system":"sec-edgar","filing":"0001567619-18-008708","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008708/doc1.xml","form_type":"4"}},{"id":3720625,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Phantom Stock Units","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":2008.0446,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Upon distribution, each phantom stock unit would have converted into one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"Pursuant to the Merger Agreement, upon closing of the Merger, each phantom stock unit was converted into a stock unit relating to the common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon distribution, each phantom stock unit would have converted into one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Basic Company Credit by the Issuer to Reporting Person's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Basic Company Credit by the Issuer to Reporting Person's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Express Scripts Holding Company Common Stock","underlying_shares":2008.0446},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720624,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":41347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":67.62,"expiration_date":"2027-03-08","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":41347},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720623,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":36551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":69.57,"expiration_date":"2026-03-09","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":36551},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720622,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":5818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":86.82,"expiration_date":"2025-12-01","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":5818},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720621,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":22171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":84.83,"expiration_date":"2025-03-04","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":22171},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720620,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":20304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":77.15,"expiration_date":"2021-03-05","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":20304},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720619,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":17507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":58.17,"expiration_date":"2020-03-06","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":17507},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720618,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":26169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":53.05,"expiration_date":"2019-02-27","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":26169},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720617,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":2325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":53.05,"expiration_date":"2019-02-27","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":2325},"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3720616,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-12-21T16:58:42.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":43800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000691/edgar.xml","form_type":"4"}},{"id":3743221,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-12-04T17:22:19.000Z","date":"2018-11-30","kind":"tax_withholding","acquired":false,"shares":165,"price":101.47,"value":16742.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans."}],"balance_after":43800,"source":{"system":"sec-edgar","filing":"0000950138-18-000643","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000643/edgar.xml","form_type":"4"}},{"id":3743220,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-12-04T17:22:19.000Z","date":"2018-11-28","kind":"gift","acquired":false,"shares":20097,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43965,"source":{"system":"sec-edgar","filing":"0000950138-18-000643","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000643/edgar.xml","form_type":"4"}},{"id":4004921,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-03-08T18:46:39.000Z","date":"2018-03-06","kind":"tax_withholding","acquired":false,"shares":3101,"price":74.58,"value":231272.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of performance shares."}],"balance_after":64062,"source":{"system":"sec-edgar","filing":"0000950138-18-000250","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000250/edgar.xml","form_type":"4"}},{"id":4004920,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-03-08T18:46:39.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":7332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vesting of performance shares granted under Express Scripts, Inc. 2011 Long-Term Incentive Plan."}],"balance_after":67163,"source":{"system":"sec-edgar","filing":"0000950138-18-000250","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000250/edgar.xml","form_type":"4"}},{"id":4004919,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-03-08T18:46:39.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":12373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on February 28, 2019, February 28, 2020, and February 28, 2021."}],"balance_after":59831,"source":{"system":"sec-edgar","filing":"0000950138-18-000250","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000250/edgar.xml","form_type":"4"}},{"id":4009912,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2018-03-06T16:21:38.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":20348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents options that were automatically exercised immediately prior to the expiration of the options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Stock option previously awarded pursuant to Express Scripts, Inc. 2000 Long-Term Incentive Plan. Options vested in three (3) equal installments on February 28, 2012, February 28, 2013, and February 28, 2014."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock option previously awarded pursuant to Express Scripts, Inc. 2000 Long-Term Incentive Plan. Options vested in three (3) equal installments on February 28, 2012, February 28, 2013, and February 28, 2014."}],"balance_after":0,"derivative":{"exercise_price":56.5,"expiration_date":"2018-03-02","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":20348},"source":{"system":"sec-edgar","filing":"0000950138-18-000232","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000232/edgar.xml","form_type":"4"}},{"id":4009911,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-03-06T16:21:38.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":16885,"price":74.77,"value":1262491.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to Company to cover payment of exercise price and Reporting Person's tax liability due upon exercise of stock option previously awarded under long-term incentive plans."}],"balance_after":47458,"source":{"system":"sec-edgar","filing":"0000950138-18-000232","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000232/edgar.xml","form_type":"4"}},{"id":4009910,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-03-06T16:21:38.000Z","date":"2018-03-02","kind":"exercise","acquired":true,"shares":20348,"price":56.5,"value":1149662.0,"ownership":{"direct":true},"balance_after":64343,"source":{"system":"sec-edgar","filing":"0000950138-18-000232","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000232/edgar.xml","form_type":"4"}},{"id":4019238,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2018-03-02T16:42:27.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":1917,"price":75.45,"value":144637.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans."}],"balance_after":43995,"source":{"system":"sec-edgar","filing":"0000950138-18-000200","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000200/edgar.xml","form_type":"4"}},{"id":4075682,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Phantom Stock Unit","published_at":"2018-02-05T16:25:01.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":189.0387,"price":78.1,"value":14763.92247,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon distribution each Phantom Stock Unit converts to one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Basic Company Credit by Express Scripts Holding Company to Participant's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Basic Company Credit by Express Scripts Holding Company to Participant's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates."}],"balance_after":2008.0446,"derivative":{"exercise_price":0,"underlying":"Express Scripts Holding Company Common Stock","underlying_shares":189.0387},"source":{"system":"sec-edgar","filing":"0000950138-18-000095","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013818000095/edgar.xml","form_type":"4"}},{"id":4141468,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2017-12-05T16:50:01.000Z","date":"2017-12-01","kind":"tax_withholding","acquired":false,"shares":121,"price":64.41,"value":7793.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans."}],"balance_after":45912,"source":{"system":"sec-edgar","filing":"0000950138-17-000782","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000782/edgar.xml","form_type":"4"}},{"id":4390483,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2017-03-10T16:06:43.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":41347,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Grant of stock option pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Vests in three equal installments on February 28, 2018, February 28, 2019, and February 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Vests in three equal installments on February 28, 2018, February 28, 2019, and February 28, 2020."}],"balance_after":41347,"derivative":{"exercise_price":67.62,"expiration_date":"2027-03-08","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":41347},"source":{"system":"sec-edgar","filing":"0000950138-17-000309","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000309/edgar.xml","form_type":"4"}},{"id":4390482,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2017-03-10T16:06:43.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":8626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on February 28, 2018, February 28, 2019, and February 28, 2020."}],"balance_after":46033,"source":{"system":"sec-edgar","filing":"0000950138-17-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000309/edgar.xml","form_type":"4"}},{"id":4390481,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2017-03-10T16:06:43.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":3420,"price":67.62,"value":231260.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of performance shares."}],"balance_after":37407,"source":{"system":"sec-edgar","filing":"0000950138-17-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000309/edgar.xml","form_type":"4"}},{"id":4390480,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2017-03-10T16:06:43.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":7921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of performance shares granted under Express Scripts, Inc. 2011 Long-Term Incentive Plan."}],"balance_after":40827,"source":{"system":"sec-edgar","filing":"0000950138-17-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000309/edgar.xml","form_type":"4"}},{"id":4408306,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2017-03-02T16:50:18.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":1732,"price":70.65,"value":122365.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans."}],"balance_after":32906,"source":{"system":"sec-edgar","filing":"0000950138-17-000246","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000246/edgar.xml","form_type":"4"}},{"id":4467906,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Phantom Stock Unit","published_at":"2017-02-03T16:04:05.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":230.3516,"price":69.11,"value":15919.599076,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon distribution each Phantom Stock Unit converts to one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Basic Company Credit by Express Scripts Holding Company to Participant's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Basic Company Credit by Express Scripts Holding Company to Participant's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates."}],"balance_after":1819.0059,"derivative":{"exercise_price":0,"underlying":"Express Scripts Holding Company Common Stock","underlying_shares":230.3516},"source":{"system":"sec-edgar","filing":"0000950138-17-000100","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013817000100/edgar.xml","form_type":"4"}},{"id":4532736,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2016-12-05T16:04:06.000Z","date":"2016-12-01","kind":"tax_withholding","acquired":false,"shares":179,"price":75.83,"value":13573.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":".Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans."}],"balance_after":34638,"source":{"system":"sec-edgar","filing":"0000950138-16-001484","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013816001484/edgar.xml","form_type":"4"}},{"id":4557220,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2016-11-14T16:02:20.000Z","date":"2016-11-09","kind":"exercise","acquired":false,"shares":21798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2000 Long-Term Incentive Plan. All shares vested on February 28, 2013."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2000 Long-Term Incentive Plan. All shares vested on February 28, 2013."}],"balance_after":0,"derivative":{"exercise_price":49.495,"expiration_date":"2017-03-03","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":21798},"source":{"system":"sec-edgar","filing":"0000950138-16-001465","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013816001465/edgar.xml","form_type":"4"}},{"id":4557219,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2016-11-14T16:02:20.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":21798,"price":75.023,"value":1635351.354,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.029, inclusive. The Reporting Person undertakes to provide to Express Scripts Holding Company, any security holder of Express Scripts Holding Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":34817,"source":{"system":"sec-edgar","filing":"0000950138-16-001465","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013816001465/edgar.xml","form_type":"4"}},{"id":4557218,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":49129,"kind":"person","name":"Miller Steven B","position":1,"cik":"0001599611","reported_name":"Miller Steven B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief Med. Officer"}}],"security":"Common Stock","published_at":"2016-11-14T16:02:20.000Z","date":"2016-11-09","kind":"exercise","acquired":true,"shares":21798,"price":49.495,"value":1078892.01,"ownership":{"direct":true},"balance_after":56615,"source":{"system":"sec-edgar","filing":"0000950138-16-001465","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532063/000095013816001465/edgar.xml","form_type":"4"}}]}